Status:
UNKNOWN
EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Mediastinal Lymphadenopathy
Lung Cancer
Eligibility:
All Genders
18-90 years
Brief Summary
This study aims on the combinatorial results of cytology, histopathology and microbiology obatined by EBUS-TBNA for unselected mediastina lesions.
Detailed Description
A number of studies have proved EBUS-TBNA to be useful for lymph node staging in lung cancer. The diagnostic performance is equivalent to mediastinoscopy while the invasiveness is far less. This study...
Eligibility Criteria
Inclusion
- Age \> 18 years old
- mediastinal lymphadenopathy on Chest CT scan
- with a short-axis \> 10mm
Exclusion
- patients intolerant to bronchoscopy exam
- unstable vital sign (Blood pressure, heart rate, breath rate)
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01493739
Start Date
January 1 2009
End Date
January 1 2012
Last Update
December 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taipei, Taipei, Taiwan, 112